CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan Eagle Pharm - EGRX CFD

-
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread -
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* N/A
Open* N/A
1-Year Change* N/A
Day's Range* N/A
52 wk Range 23.87-52.22
Average Volume (10 days) 337.94K
Average Volume (3 months) 3.27M
Market Cap 350.54M
P/E Ratio 9.77
Shares Outstanding 13.02M
Revenue 316.61M
EPS 2.76
Dividend (Yield %) N/A
Beta 0.91
Next Earnings Date May 8, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low

Eagle Pharm Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 171.546 187.802 195.892 213.312 236.707
Revenue 171.546 187.802 195.892 213.312 236.707
Cost of Revenue, Total 42.18 45.465 60.897 61.916 57.186
Gross Profit 129.366 142.337 134.995 151.396 179.521
Total Operating Expense 168.777 154.848 174.077 176.696 162.717
Selling/General/Admin. Expenses, Total 75.322 78.598 76.37 60.509 71.416
Research & Development 51.275 30.785 36.81 44.419 32.607
Unusual Expense (Income) 0 0 10.615 8.885
Operating Income 2.769 32.954 21.815 36.616 73.99
Interest Income (Expense), Net Non-Operating -7.275 -2.015 -0.517 -2.578 -1.045
Other, Net -0.042 -8.262 0.7
Net Income Before Taxes -4.548 22.677 21.998 34.038 72.945
Net Income After Taxes -8.627 11.989 14.313 31.903 55.343
Net Income Before Extra. Items -8.627 11.989 14.313 31.903 55.343
Net Income -8.627 11.989 14.313 31.903 51.943
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items -8.627 11.989 14.313 31.903 55.343
Income Available to Common Incl. Extra. Items -8.627 11.989 14.313 31.903 51.943
Diluted Net Income -8.627 11.989 14.313 31.903 51.943
Diluted Weighted Average Shares 13.0511 13.7714 14.1387 15.2787 15.9082
Diluted EPS Excluding Extraordinary Items -0.66102 0.87057 1.01233 2.08808 3.4789
Diluted Normalized EPS -0.66102 0.87057 1.01233 2.73926 3.90264
Other Operating Expenses, Total 0 0 -0.763 -7.377
Total Extraordinary Items -3.4
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 115.874 42.32 39.853 48.124 41.249
Revenue 115.874 42.32 39.853 48.124 41.249
Cost of Revenue, Total 27.755 12.309 8.259 10.757 10.855
Gross Profit 88.119 30.011 31.594 37.367 30.394
Total Operating Expense 56.045 36.421 50.03 37.304 45.022
Selling/General/Admin. Expenses, Total 22.182 20.325 18.482 16.636 19.879
Research & Development 6.108 3.787 23.289 9.911 14.288
Operating Income 59.829 5.899 -10.177 10.82 -3.773
Interest Income (Expense), Net Non-Operating -2.712 -4.53 -2.499 -5.459 5.213
Other, Net 0.543 -0.145 0.016 0.187 -0.1
Net Income Before Taxes 57.66 1.224 -12.66 5.548 1.34
Net Income After Taxes 44.058 -6.196 -5.622 3.612 -0.421
Net Income Before Extra. Items 44.058 -6.196 -5.622 3.612 -0.421
Net Income 44.058 -6.196 -5.622 3.612 -0.421
Income Available to Common Excl. Extra. Items 44.058 -6.196 -5.622 3.612 -0.421
Income Available to Common Incl. Extra. Items 44.058 -6.196 -5.622 3.612 -0.421
Diluted Net Income 44.058 -6.196 -5.622 3.612 -0.421
Diluted Weighted Average Shares 12.9068 12.8948 13.0773 13.2622 13.0694
Diluted EPS Excluding Extraordinary Items 3.41355 -0.4805 -0.42991 0.27235 -0.03221
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 3.41355 -0.4805 -0.42991 0.27235 -0.03221
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 172.606 166.065 179.449 163.844 188.697
Cash and Short Term Investments 97.659 103.155 109.775 78.791 114.657
Cash & Equivalents 97.659 103.155 109.775 78.791 114.657
Total Receivables, Net 41.149 51.117 48.004 66.486 53.821
Accounts Receivable - Trade, Net 41.149 51.117 48.004 66.486 53.821
Total Inventory 21.908 8.075 6.566 8.304 5.118
Prepaid Expenses 11.89 3.718 15.104 10.263 15.101
Total Assets 253.732 253.19 254.554 238.603 270.06
Property/Plant/Equipment, Total - Net 1.636 2.077 5.918 2.397 6.82
Property/Plant/Equipment, Total - Gross 7.591 7.268 10.237 5.744 9.258
Accumulated Depreciation, Total -5.955 -5.191 -4.319 -3.347 -2.438
Goodwill, Net 39.743 39.743 39.743 39.743 39.743
Intangibles, Net 10.671 12.917 15.583 18.103 23.322
Other Long Term Assets, Total 29.076 32.388 13.861 14.516 11.478
Total Current Liabilities 74.376 38.085 38.823 39.686 47.302
Accounts Payable 16.431 6.268 5.462 9.917 27.036
Accrued Expenses 32.338 23.817 28.361 23.519 15.391
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total
Total Liabilities 77.279 67.179 75.38 77.841 90.916
Total Long Term Debt 0 25.135 33.557 38.155 42.905
Other Liabilities, Total 2.903 3.959 3 0 0.709
Total Equity 176.453 186.011 179.174 160.762 179.144
Common Stock 0.017 0.017 0.017 0.017 0.016
Additional Paid-In Capital 325.779 305.403 278.518 256.458 233.639
Retained Earnings (Accumulated Deficit) 75.862 84.489 72.5 58.187 26.284
Treasury Stock - Common -225.111 -203.898 -171.861 -153.9 -80.795
Total Liabilities & Shareholders’ Equity 253.732 253.19 254.554 238.603 270.06
Total Common Shares Outstanding 12.7914 13.057 13.6302 13.914 14.8477
Current Port. of LT Debt/Capital Leases 25.607 8 5 6.25 4.875
Long Term Debt 0 25.135 33.557 38.155 42.905
Redeemable Preferred Stock 0 0 0 0
Other Equity, Total -0.094
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 240.166 172.606 171.694 175.504 163.986
Cash and Short Term Investments 69.522 97.659 99.741 108.717 105.229
Cash & Equivalents 69.522 97.659 99.741 108.717 105.229
Total Receivables, Net 130.858 41.149 47.081 52.659 44.868
Accounts Receivable - Trade, Net 130.858 41.149 45.335 52.659 44.868
Total Inventory 24.818 21.908 9.315 8.294 6.862
Prepaid Expenses 14.968 11.89 15.557 5.834 7.027
Total Assets 320.165 253.732 256.261 264.242 259.968
Property/Plant/Equipment, Total - Net 1.627 1.636 1.775 1.967 2.27
Property/Plant/Equipment, Total - Gross 7.759 7.591 7.542 7.537 7.652
Accumulated Depreciation, Total -6.132 -5.955 -5.767 -5.57 -5.382
Goodwill, Net 39.743 39.743 39.743 39.743 39.743
Intangibles, Net 9.94 10.671 10.799 11.505 12.211
Other Long Term Assets, Total 28.689 29.076 32.25 35.523 41.758
Total Current Liabilities 101.642 74.376 48.431 44.664 41.973
Accounts Payable 14.509 16.431 12.717 11.136 12.559
Accrued Expenses 63.408 32.338 27.714 25.528 21.414
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 23.725 25.607 8 8 8
Total Liabilities 104.205 77.279 70.968 69.395 68.89
Total Long Term Debt 0 0 19.489 21.371 23.253
Long Term Debt 0 19.489 21.371 23.253
Other Liabilities, Total 2.563 2.903 3.048 3.36 3.664
Total Equity 215.96 176.453 185.293 194.847 191.078
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.017 0.017 0.017 0.017 0.017
Additional Paid-In Capital 328.769 325.779 320.566 316.249 312.323
Retained Earnings (Accumulated Deficit) 119.92 75.862 82.058 87.68 84.068
Treasury Stock - Common -233.164 -225.111 -216.466 -208.195 -205.33
Total Liabilities & Shareholders’ Equity 320.165 253.732 256.261 264.242 259.968
Total Common Shares Outstanding 12.6971 12.7914 12.9446 13.0971 13.1455
Other Equity, Total 0.418 -0.094 -0.882 -0.904
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -8.627 11.989 14.313 31.903 51.943
Cash From Operating Activities 28.219 49.497 55.986 52.384 58.919
Cash From Operating Activities 0.764 0.872 2.131 1.155 0.932
Amortization 2.996 2.666 2.52 2.515 2.815
Deferred Taxes -3.618 -1.511 0.152 -2.468 17.289
Non-Cash Items 27.167 34.665 22.478 27.168 15.509
Cash Taxes Paid 10.005 6.428 6.673 2.281 10.542
Cash Interest Paid 1.197 2.224 2.478 2.084 0.651
Changes in Working Capital 9.537 0.816 14.392 -7.889 -29.569
Cash From Investing Activities -5.323 -18.247 -0.777 -0.133 -5.186
Capital Expenditures -0.323 -0.747 -0.777 -0.133 -5.186
Other Investing Cash Flow Items, Total -5 -17.5 0 0
Cash From Financing Activities -28.392 -37.87 -24.225 -88.117 8.104
Financing Cash Flow Items -1.577 -1.525 -0.524 -19.877 -1.192
Issuance (Retirement) of Stock, Net -18.815 -31.345 -17.701 -64.49 -39.454
Net Change in Cash -5.496 -6.62 30.984 -35.866 61.837
Issuance (Retirement) of Debt, Net -8 -5 -6 -3.75 48.75
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 44.058 -8.627 -2.431 3.191 -0.421
Cash From Operating Activities -16.611 28.219 20.138 19.071 10.478
Cash From Operating Activities 0.177 0.764 0.575 0.378 0.19
Amortization 0.731 2.996 2.118 1.412 0.706
Deferred Taxes -2.432 -3.618 -2.533 1.119 0.902
Non-Cash Items 6.616 27.167 17.689 10.989 1.378
Cash Taxes Paid 0.041 10.005 6.303 4.3 0.267
Cash Interest Paid 0.265 1.197 0.917 0.625 0.321
Changes in Working Capital -65.761 9.537 4.72 1.982 7.723
Cash From Investing Activities -0.168 -5.323 -5.274 -5.269 -5.384
Capital Expenditures -0.168 -0.323 -0.274 -0.269 -0.384
Other Investing Cash Flow Items, Total 0 -5 -5 -5 -5
Cash From Financing Activities -11.358 -28.392 -18.278 -8.24 -3.02
Financing Cash Flow Items -1.305 -1.577 -1.551 -1.551 -1.551
Issuance (Retirement) of Stock, Net -8.053 -18.815 -10.727 -2.689 0.531
Issuance (Retirement) of Debt, Net -2 -8 -6 -4 -2
Net Change in Cash -28.137 -5.496 -3.414 5.562 2.074
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 12.5669 1635783 7863 2022-12-31 LOW
Tarriff (Scott L) Individual Investor 12.3402 1606275 70900 2023-03-01 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 9.4485 1229872 -9907 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 7.3139 952026 -59721 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 5.8538 761974 -11708 2022-12-31 LOW
Brandes Investment Partners, L.P. Investment Advisor 3.1973 416177 -51680 2022-12-31 LOW
Adage Capital Management, L.P. Hedge Fund 3.073 400000 150000 2022-12-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 2.6858 349606 -6153 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 2.0485 266650 -7629 2022-12-31 HIGH
Acadian Asset Management LLC Investment Advisor/Hedge Fund 1.7792 231587 -79633 2022-12-31 MED
Smith, Graham & Co. Investment Advisors, L.P. Investment Advisor 1.7764 231222 -799 2022-12-31 LOW
Quoniam Asset Management GmbH Investment Advisor/Hedge Fund 1.766 229871 -55740 2022-12-31 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.5388 200305 3708 2022-12-31 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 1.2517 162931 19807 2022-12-31 LOW
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 1.231 160236 -2596 2022-12-31 LOW
LSV Asset Management Investment Advisor 1.1633 151418 126068 2022-12-31 LOW
Allspring Global Investments, LLC Investment Advisor/Hedge Fund 1.1572 150628 62456 2022-12-31 LOW
Scout Investments, Inc. Investment Advisor 1.0805 140642 -2342 2022-12-31 MED
AQR Capital Management, LLC Investment Advisor/Hedge Fund 1.0396 135315 39400 2022-12-31 LOW
Morgan Stanley & Co. LLC Research Firm 1.0331 134477 -15478 2022-12-31 MED

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Proprietary & Advanced Pharmaceuticals

50 Tice Boulevard, Suite 315
WOODCLIFF LAKE
NEW JERSEY 07677
US

Income Statement

  • Annual
  • Quarterly

People also watch

XRP/USD

0.44 Price
+3.600% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00422

Gold

1,978.29 Price
+0.370% 1D Chg, %
Biaya inap posisi Long -0.0086%
Biaya inap posisi short 0.0004%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

US100

12,701.20 Price
+1.090% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.9

Oil - Crude

70.13 Price
+0.370% 1D Chg, %
Biaya inap posisi Long -0.0170%
Biaya inap posisi short -0.0050%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda